Avanos Medical, Inc. has announced an agreement to acquire Diros Technology Inc., a leading manufacturer of innovative radiofrequency (RF) products used to treat chronic pain conditions. The acquisition is expected to enhance Avanos' pain management treatment options and complement its premium COOLIEF* Cooled Radiofrequency product offering with the addition of Diros' unique RF Trident™ technology. This comprehensive suite of RF offerings is believed to position Avanos for future growth across all major sites of patient care.
Avanos Medical has revealed that it will be acquiring Diros Technology, a renowned producer of state-of-the-art radiofrequency products that are used in treating chronic pain conditions. With over one million RFA procedures carried out annually worldwide, Diros Technology's products deliver RF energy through precisely placed probes that heat nervous tissue near the probe's tip, deactivating the nerve's ability to transmit pain signals. By incorporating their unique RF Trident™ technology into their own, Avanos hopes to expand their portfolio in the treatment of chronic musculoskeletal pain.Avanos will finance the acquisition through a combination of funds from its existing credit facility and available cash. The company estimates that the new business will